| 翻訳と辞書 |
| Marathon Pharmaceuticals ： ウィキペディア英語版 |
Marathon Pharmaceuticals
Marathon Pharmaceuticals LLC is a privately held biopharmaceuticals company focused on drugs for people with rare diseases.〔(【引用サイトリンク】url=https://www.rarediseases.org/ )〕 The Northbrook, Illinois-based company develops and manufactures therapeutics and brings them to market. It employs 100 people in four global locations.
== Business model ==
Marathon produces medicines for high-need, small patient populations, including patients with rare diseases as outlined by the U.S. Food and Drug Administration’s (FDA) Orphan Drug Act. The Act defines rare diseases as impacting fewer than 200,000 patients in the U.S.
Marathon develops late-stage drugs, earns regulatory approvals, and then manufactures and commercializes medicines with input from patient advocacy groups. Marathon’s regulatory efforts center on gaining FDA approval of New Drug Applications (NDA) or Biologic License Applications (BLA).〔(【引用サイトリンク】url=http://www.fda.gov/biologicsbloodvaccines/developmentapprovalprocess/biologicslicenseapplicationsblaprocess/default.htm )〕
The company provides assistance for eligible patients with financial hardship and helps patients secure other assistance through the National Organization of Rare Disorders (NORD) and similar patient support groups.〔(【引用サイトリンク】url=http://marathonpharma.com/patient-support-program )〕
Marathon distributes its products in North America.
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Marathon Pharmaceuticals」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|